Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase EARLY_PHASE1 4Phase 1/2 3Phase 3 2Phase 1 2Phase NA 1

Status

Active not recruiting 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 4

Conditions

Breast Neoplasms 161Neoplasms 95Prostatic Neoplasms 86Glioblastoma 76Multiple Myeloma 65Pancreatic Neoplasms 63Glioma 61Brain Neoplasms 56Lung Neoplasms 46Carcinoma, Hepatocellular 44Melanoma 43Head and Neck Neoplasms 43Recurrence 41Carcinoma, Non-Small-Cell Lung 41Leukemia, Myeloid, Acute 40Colorectal Neoplasms 38Squamous Cell Carcinoma of Head and Neck 35Ovarian Neoplasms 35Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Neoplasm Metastasis 29Lymphoma, Non-Hodgkin 29Lymphoma 28Carcinoma, Renal Cell 28Polycystic Ovary Syndrome 27Stomach Neoplasms 24Hematologic Neoplasms 23Lymphoma, B-Cell 22Sarcoma 21Endometrial Neoplasms 20Uterine Cervical Neoplasms 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × OTHER × Sarcoma, Alveolar Soft Part × Clear all
NCT06789081 2026-03-23

GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma (CLIC-YYC-GPNMB-02)

AHS Cancer Control Alberta

Phase EARLY_PHASE1 Active not recruiting
1 enrolled
Sarcoma

Sarcoma, Alveolar Soft Part

NCT07104682 2025-08-05

CLIC-YYC-GPNMB

University of Calgary

Phase EARLY_PHASE1 Not yet recruiting
1 enrolled
Sarcoma

Sarcoma, Sarcoma, Alveolar Soft Part

NCT06827886 2025-07-23

GCAR1

AHS Cancer Control Alberta

Phase EARLY_PHASE1 Completed
1 enrolled
Sarcoma

Sarcoma, Alveolar Soft Part

NCT06813417 2025-04-10

SPS-Q2

University of Calgary

Phase EARLY_PHASE1 Active not recruiting
1 enrolled
Sarcoma

Sarcoma, Sarcoma, Alveolar Soft Part

Data powered by HemOnc (CC BY 4.0) Colophon âš¡